Kazia Therapeutics (KZIA) Enterprise Value (2017 - 2025)
Kazia Therapeutics' Enterprise Value history spans 6 years, with the latest figure at -$2.8 million for Q2 2025.
- For Q2 2025, Enterprise Value fell 152.18% year-over-year to -$2.8 million; the TTM value through Jun 2025 reached -$2.8 million, down 152.18%, while the annual FY2025 figure was -$2.8 million, 152.18% down from the prior year.
- Enterprise Value reached -$2.8 million in Q2 2025 per KZIA's latest filing, down from -$1.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q2 2024 to a low of -$5.3 million in Q2 2022.
- Average Enterprise Value over 4 years is -$3.2 million, with a median of -$3.1 million recorded in 2023.
- Peak YoY movement for Enterprise Value: skyrocketed 68.83% in 2024, then plummeted 152.18% in 2025.
- A 4-year view of Enterprise Value shows it stood at -$5.3 million in 2022, then soared by 33.56% to -$3.5 million in 2023, then surged by 68.83% to -$1.1 million in 2024, then tumbled by 152.18% to -$2.8 million in 2025.
- Per Business Quant, the three most recent readings for KZIA's Enterprise Value are -$2.8 million (Q2 2025), -$1.1 million (Q2 2024), and -$3.5 million (Q2 2023).